Peralkaline rhyolites, associated with extensional tectonic settings, are medium to low viscosity magmas that often produce eruptive styles ranging from effusive to highly explosive eruptions. The role of pre-eruptive conditions and crystallization kinetics in influencing the eruptive style of peralkaline rhyolitic magmas has been investigated and debated considering equilibrium conditions. However, experimental constraints on the effect of disequilibrium in crystallization in such magmas are currently lacking in the literature. Therefore, we performed isobaric cooling experiments to investigate alkali feldspar crystallization kinetics in peralkaline rhyolitic melts. Experiments were performed under water-saturated, water-undersaturated, and anhydrous conditions between 25 and 100 MPa, at 670-790 • C and with experimental durations ranging from 0.5 to 420 h. Here we present the first data on crystallization kinetics of alkali feldspar, which is the main crystal phase in peralkaline rhyolitic melts, in order to improve our understanding of the evolutionary timescales of these melts and their ability to shift between effusive and explosive activity. Our experimental results indicate that the alkali feldspar nucleation delay can range from hours to several days as a function of undercooling and H 2 O content in the melt. Thus, a peralkaline rhyolitic magma can be stored at the pre-eruptive conditions for days without important variations of its crystal fraction. This suggests that crystallization may not necessarily play the main role in triggering fragmentation during explosive eruptions of peralkaline rhyolitic magmas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.